Drug firms tired song and dance on reform

In an April Wall Street Journal story, Credit Suisse analyst Catherine Arnold detailed how Bristol-Myers Squibb, Pfizer, and Eli Lilly raised the prices of leukemia, kidney cancer, attention deficit, and erectile function drugs (including Pfizers Viagra...